Connecticut SB 251: AN ACT CONCERNING THE AVAILABILITY OF GENERIC PHARMACEUTICALS.

Status: FILED WITH LCO (as of 2020-03-11)

State: Connecticut · Session: 2020 · Bill: SB 251

Subjects: Drugs, Fines (Penalties), Patents, Pharmaceutical industry

Sponsors: Anwar, Saud, Looney, Martin M.

View Connecticut SB 251 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.